Donor cell-derived transient abnormal myelopoiesis as a specific complication of umbilical cord blood transplantation
Bone Marrow Transplant
.
2018 Feb;53(2):225-227.
doi: 10.1038/bmt.2017.226.
Epub 2017 Oct 9.
Authors
N Hiramoto
1
,
J Takeda
2
,
K Yoshida
2
,
Y Ono
3
,
S Yoshioka
3
,
N Yamauchi
3
,
A Fujimoto
3
,
H Maruoka
4
,
Y Shiraishi
5
,
H Tanaka
5
,
K Chiba
5
,
Y Imai
6
,
S Miyano
5
,
S Ogawa
2
,
T Ishikawa
3
Affiliations
1
Department of Cell Therapy, Institute of Biomedical Research and Innovation, Kobe, Japan.
2
Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
3
Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
4
Department of Clinical Laboratory, Kobe City Medical Center General Hospital, Kobe, Japan.
5
Laboratory of DNA Information Analysis, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
6
Department of Clinical Pathology, Kobe City Medical Center General Hospital, Kobe, Japan.
PMID:
28991249
DOI:
10.1038/bmt.2017.226
No abstract available
Publication types
Case Reports
Letter
MeSH terms
Cord Blood Stem Cell Transplantation / adverse effects*
Female
Humans
Middle Aged
Myelopoiesis / genetics*
Retrospective Studies
Tissue Donors